Literature DB >> 10197732

Dose-dependent antibody response to influenza H1N1 vaccine component in elderly nursing home patients.

E J Remarque1, J M de Jong, R J van der Klis, N Masurel, G J Ligthart.   

Abstract

The effects of an increased antigen dose on HI, IgG, IgA, and IgM antibody responses to influenza A/Taiwan/1/86 (H1N1) were investigated in 92 elderly nursing-home residents (mean age 81 years) and 104 young subjects (mean age 20 years). At a standard 10-microg dose, HI and IgG titer rises were lower in the elderly. HI titers did not improve at higher vaccine dosages. By contrast, influenza-specific IgG and IgA antibody responses were dose dependent in elderly subjects, but not in young. In the young subjects, IgM antibody responses were dose dependent. The improved antibody responses in the elderly as observed in IgG and IgA were not reflected in the HI response. Therefore, the evaluation of antibody production by HI only may lead to an underestimate of the immune response in elderly people.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10197732     DOI: 10.1016/s0531-5565(98)00060-6

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  3 in total

1.  Unique biomarkers for B-cell function predict the serum response to pandemic H1N1 influenza vaccine.

Authors:  Daniela Frasca; Alain Diaz; Maria Romero; Mitch Phillips; Nicholas V Mendez; Ana Marie Landin; Bonnie B Blomberg
Journal:  Int Immunol       Date:  2012-01-25       Impact factor: 4.823

2.  Response to influenza vaccine in people with non-protective HI antibody titers.

Authors:  Vincenzo Baldo; Tatjana Baldovin; Annarosa Floreani; Michele Minuzzo; Renzo Trivello
Journal:  Eur J Epidemiol       Date:  2006-11-03       Impact factor: 8.082

3.  Circulating CXCR5+PD-1+ response predicts influenza vaccine antibody responses in young adults but not elderly adults.

Authors:  Ramin Sedaghat Herati; Morgan A Reuter; Douglas V Dolfi; Kathleen D Mansfield; Htin Aung; Osama Z Badwan; Raj K Kurupati; Senthil Kannan; Hildegund Ertl; Kenneth E Schmader; Michael R Betts; David H Canaday; E John Wherry
Journal:  J Immunol       Date:  2014-08-29       Impact factor: 5.422

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.